Insurance Companies and TLT-PDT...We all know that TLT-Ruvidar is a ''one and done treatment'', is 100% safe, has no restrictions, and most of all has the best CR% in the business.
We also know that Insurance Companies love to save money.
Question?
How can Insurance Companies save money with TLT-PDT treatment?
In this link(from the American Cancer Society)...
PDT | What is PDT? | Photodynamic Therapy | American Cancer Society Under Pros of PDT...
1) PDT has no long-term side effects when used properly.
Note: Side effects cost money to Insurance Companies. 2)It's less invasive than surgery.
3) It is most often done as an Outpatient Procedure.
Note:Outpatient Procedure = No huge hospital stay bill to pay for Insurance Companies. 4)Can be targeted very precisely.
5) It can be repeated many times at the same site if needed.
6) There is usually little or no scarring after site heals.
Note: Insurance Companies will love the next pros of PDT...
According to the American Cancer Society...
7) It(PDT) often costs less than other treatments. Wow!!!!Very interesting.
TLT-Ruvidar has the best CR% in the business, and in term of cost, TLT-PDT could be the most affordable treatment for BCG-Resistant patients.
To conclude...
Once TLT-Ruvidar has been fully approved by the FDA, all the above will be a nice incentive for Insurance Companies, to propose TLT-Ruvidar to their BCG-Resistant clienteles.
The more you learn about TLT-PDT, the more you love your TLT shares.